Breaking News Instant updates and real-time market news.

CANF

Can-Fite BioPharma

$1.62

-0.02 (-1.22%)

07:05
08/23/17
08/23
07:05
08/23/17
07:05

Can-Fite BioPharma receives mileston payment from CKD

Can-Fite BioPharma announced it has received a milestone payment in the amount of $500,000 from Chong Kun Dang Pharmaceuticals, which has licensed the exclusive right to distribute Namodenosonfor the treatment of liver cancer in Korea upon receipt of regulatory approvals. This is the second payment received by Can-Fite, as part of the Korean distribution agreement with CKD which is valued at up to $3M in upfront and milestone payments plus 23% royalties on sales of Namodenoson. Can-Fite has received $1M to date from CKD and may receive up to an additional $2,000,000 in milestone payments. Under the distribution agreement with CKD, Can-Fite will supply Namodenoson to CKD, which will be responsible for all costs and activities associated with development, regulatory approvals, marketing, sales and distribution of Namodenoson in Korea. This agreement with CKD marks Can-Fite's second distribution and licensing deal in Korea, where the Company's drug candidate Piclidenoson has been out-licensed to Kwang Dong Pharmaceutical Co. for the treatment of rheumatoid arthritis.

CANF Can-Fite BioPharma
$1.62

-0.02 (-1.22%)

08/11/17
MAXM
08/11/17
INITIATION
Target $7
MAXM
Buy
Can-Fite BioPharma initiated with a Buy at Maxim
Maxim analyst Jason McCarthy started Can-Fite Biopharma with a Buy rating, stating that the company has multiple shots on goal in "blockbuster-sized indications" with its A3AR targeting drug piclidenoson. The analyst, who models piclidenoson commercialization in rheumatoid arthritis in 2022 followed by psoriasis in 2023, set a $7 price target on Can-Fite shares.
10/19/16
ROTH
10/19/16
INITIATION
Target $4
ROTH
Buy
Can-Fite BioPharma reinstated with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv resumed coverage of Can-Fite BioPharma with a Buy rating and $4 price target, saying the company's diversified pipeline offers "multiple shots on goal" and is relatively undervalued. The analyst expects that positive data and management execution over the coming 12-24 months could present investible catalysts.
08/29/16
RODM
08/29/16
INITIATION
Target $6
RODM
Buy
Can-Fite BioPharma assumed with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Raghuram Selvaraju assumed coverage of Can-Fite BioPharma with a Buy rating and $6 price target.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,126.31

-3.57 (-0.32%)

15:57
11/21/17
11/21
15:57
11/21/17
15:57
Hot Stocks
Amazon cuts prices for AWS IoT customers by 20%-40% »

Amazon said this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

T

AT&T

$34.42

-0.22 (-0.64%)

, TWX

Time Warner

$89.35

1.64 (1.87%)

15:43
11/21/17
11/21
15:43
11/21/17
15:43
Hot Stocks
Trump says AT&T, Time Warner deal not good for the country »

President Donald Trump,…

T

AT&T

$34.42

-0.22 (-0.64%)

TWX

Time Warner

$89.35

1.64 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

GES

Guess

$18.11

0.33 (1.86%)

15:40
11/21/17
11/21
15:40
11/21/17
15:40
Options
Active trading in Guess ahead of earnings »

Active trading in Guess…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BZUN

Baozun

$36.16

0.66 (1.86%)

15:34
11/21/17
11/21
15:34
11/21/17
15:34
Options
Baozun options imply 15.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

OSUR

OraSure

$13.96

0.22 (1.60%)

15:32
11/21/17
11/21
15:32
11/21/17
15:32
Hot Stocks
OraSure jumps after $143M Oragene Dx devices deal »

Shares of OraSure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.94

0.185 (0.18%)

15:30
11/21/17
11/21
15:30
11/21/17
15:30
Periodicals
John Lasseter taking leave of absence from Pixar, notes 'missteps,' THR reports »

Disney Animation head…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTR

Dollar Tree

$97.11

2.5 (2.64%)

15:28
11/21/17
11/21
15:28
11/21/17
15:28
Recommendations
Dollar Tree analyst commentary  »

Dollar Tree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MPB

Mid Penn Bancorp

$30.37

-0.7242 (-2.33%)

15:25
11/21/17
11/21
15:25
11/21/17
15:25
Hot Stocks
Mid Penn Bancorp declares quarterly dividend of 15c per share »

Payable on January 12,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$30.37

-0.7242 (-2.33%)

15:24
11/21/17
11/21
15:24
11/21/17
15:24
Hot Stocks
Mid Penn Bancorp declares special dividend of 10c per share »

Payable on January 5,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IZEA

Izea

$4.35

-0.17 (-3.76%)

15:20
11/21/17
11/21
15:20
11/21/17
15:20
Hot Stocks
Breaking Hot Stocks news story on Izea »

Izea halted after jumping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.61

-0.41 (-0.84%)

15:20
11/21/17
11/21
15:20
11/21/17
15:20
Options
Bullish option play opened in Oracle »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IZEA

Izea

$4.35

-0.17 (-3.76%)

15:19
11/21/17
11/21
15:19
11/21/17
15:19
Hot Stocks
Izea announces signing of 'one of largest grocery chains in U.S' »

In a tweet on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.45

0.01 (0.06%)

15:19
11/21/17
11/21
15:19
11/21/17
15:19
Options
GameStop options imply 15.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ACIU

AC Immune

$10.37

-0.24 (-2.26%)

15:17
11/21/17
11/21
15:17
11/21/17
15:17
Conference/Events
AC Immune to hold a KOL luncheon meeting »

Key Opinion Leader (KOL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
11/21/17
11/21
15:17
11/21/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/21/17
11/21
15:16
11/21/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
11/21/17
11/21
15:15
11/21/17
15:15
General news
Treasury Option Action: big buyer of put protection in the belly »

Treasury Option Action:…

UA

Under Armour

$11.47

-0.6 (-4.97%)

, UAA

Under Armour

$12.92

-0.52 (-3.87%)

15:11
11/21/17
11/21
15:11
11/21/17
15:11
Technical Analysis
Technical View: Under Armour near lows of the day, levels to watch »

The shares were last down…

UA

Under Armour

$11.47

-0.6 (-4.97%)

UAA

Under Armour

$12.92

-0.52 (-3.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.85

-0.0134 (-1.55%)

15:09
11/21/17
11/21
15:09
11/21/17
15:09
Hot Stocks
DelMar presents 'positive' interim results from VAL-083 study »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

15:06
11/21/17
11/21
15:06
11/21/17
15:06
Hot Stocks
ProQR Therapeutics treatment of retinitis pigmentosa granted FDA orphan status »

The FDA granted ProQR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

15:05
11/21/17
11/21
15:05
11/21/17
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

HPE

HP Enterprise

$14.16

0.065 (0.46%)

15:04
11/21/17
11/21
15:04
11/21/17
15:04
Options
Hewlett Packard Enterprise options imply 6.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 11

    Dec

UA

Under Armour

$11.40

-0.675 (-5.59%)

, UAA

Under Armour

$12.88

-0.565 (-4.20%)

15:03
11/21/17
11/21
15:03
11/21/17
15:03
Periodicals
Head of footwear business leaving Under Armour, WSJ says »

Peter Ruppe, the senior…

UA

Under Armour

$11.40

-0.675 (-5.59%)

UAA

Under Armour

$12.88

-0.565 (-4.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$3.68

0.15 (4.25%)

15:01
11/21/17
11/21
15:01
11/21/17
15:01
Conference/Events
Amyris to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

TRIP

TripAdvisor

$30.48

-0.11 (-0.36%)

14:55
11/21/17
11/21
14:55
11/21/17
14:55
Periodicals
FTC investigating TripAdvisor's business practices, MJS reports »

The U.S. Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.